Robert A. McCabe Jr., chairman of two publicly traded companies, has demonstrated a clear selling bias in his recent insider transactions, with $13.1 million in total sales outweighing $2.5 million in purchases across his holdings. His activity centers on National Health Investors (NHI) and Pinnacle Financial Partners (PNFP), with the most significant transactions occurring in early 2026. On January 1, 2026, McCabe executed a $7.6 million disposition of PNFP shares through a derivative transaction (Code F), following a $2.4 million derivative sale on December 26, 2025. These large-scale PNFP transactions were preceded by a $630,075 open-market sale (Code S) on November 26, 2025. His NHI activity shows a similar pattern, with two derivative dispositions totaling $2.5 million in January and February 2026, offset only by a modest $28,768 purchase in May 2024. The transaction codes indicate McCabe has primarily used derivative instruments (Code F) rather than open-market sales for his largest dispositions, with the most recent activity showing zero-value acquisitions (Code A) likely representing equity awards. The data reveals a multiyear trend of monetizing positions in both holdings, with particularly concentrated selling in PNFP during late 2025 and early 2026.
AI-assisted summary